These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1656849)

  • 1. Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia.
    Azoulay-Dupuis E; Vallée E; Bedos JP; Muffat-Joly M; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1024-8. PubMed ID: 1656849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between macrolide lung pharmacokinetics and therapeutic efficacy in a mouse model of pneumococcal pneumonia.
    Veber B; Vallée E; Desmonts JM; Pocidalo JJ; Azoulay-Dupuis E
    J Antimicrob Chemother; 1993 Sep; 32(3):473-82. PubMed ID: 8262870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.
    Azoulay-Dupuis E; Mohler J; Bédos JP; Barau C; Fantin B
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3033-8. PubMed ID: 16940099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.
    Girard AE; Girard D; English AR; Gootz TD; Cimochowski CR; Faiella JA; Haskell SL; Retsema JA
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1948-54. PubMed ID: 2830841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection.
    Vallée E; Azoulay-Dupuis E; Pocidalo JJ; Bergogne-Bérézin E
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1412-7. PubMed ID: 1324644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
    Kim MK; Zhou W; Tessier PR; Xuan D; Ye M; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3185-92. PubMed ID: 12234843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual efficacy of clarithromycin (A-56268) and its major human metabolite 14-hydroxy clarithromycin (A-62671) in experimental pneumococcal pneumonia in the mouse.
    Bédos JP; Azoulay-Dupuis E; Vallée E; Veber B; Pocidalo JJ
    J Antimicrob Chemother; 1992 Jun; 29(6):677-85. PubMed ID: 1387132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.
    den Hollander JG; Knudsen JD; Mouton JW; Fuursted K; Frimodt-Møller N; Verbrugh HA; Espersen F
    Antimicrob Agents Chemother; 1998 Feb; 42(2):377-82. PubMed ID: 9527789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.
    Wang E; Simard M; Bergeron Y; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1010-8. PubMed ID: 10722505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    Gill CJ; Abruzzo GK; Flattery AM; Smith JG; Jackson J; Kong L; Wilkening R; Shankaran K; Kropp H; Bartizal K
    J Antibiot (Tokyo); 1995 Oct; 48(10):1141-7. PubMed ID: 7490222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin.
    Azoulay-Dupuis E; Bedos JP; Vallée E; Pocidalo JJ
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():45-53. PubMed ID: 1664829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia.
    Azoulay-Dupuis E; Mohler J; Bédos JP
    Antimicrob Agents Chemother; 2004 Jan; 48(1):80-5. PubMed ID: 14693522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae.
    Piroth L; Desbiolles N; Mateo-Ponce V; Martin L; Lequeu C; Charles PE; Portier H; Chavanet P
    J Antimicrob Chemother; 2001 Jan; 47(1):33-42. PubMed ID: 11152429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G.
    Tissi L; von Hunolstein C; Mosci P; Campanelli C; Bistoni F; Orefici G
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1938-47. PubMed ID: 8540695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
    Azoulay-Dupuis E; Vallee E; Veber B; Bedos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2698-703. PubMed ID: 1336343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia.
    Yoshioka D; Kajiwara C; Ishii Y; Umeki K; Hiramatsu K; Kadota J; Tateda K
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6146-54. PubMed ID: 27480866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
    Girard AE; Cimochowski CR; Faiella JA
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():29-37. PubMed ID: 8396094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.
    Bohte R; van't Wout JW; Lobatto S; Blussé van Oud Alblas A; Boekhout M; Nauta EH; Hermans J; van den Broek PJ
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):182-7. PubMed ID: 7614957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia.
    Mohler J; Azoulay-Dupuis E; Amory-Rivier C; Mazoit JX; Bédos JP; Rieux V; Moine P
    Intensive Care Med; 2003 May; 29(5):808-16. PubMed ID: 12665994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.